New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain

New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases. New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases. New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases. Silymarin may help sugar-control in people with type II diabetes Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels. Silymarin may help sugar-control in people with type II diabetes Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels. Silymarin may help sugar-control in people with type II diabetes Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Landmark Study Shows Diachrome(R) Significantly Improves Blood Sugar Control in People with Type 2 Diabetes Company announces new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome(R) significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs). Landmark Study Shows Diachrome(R) Significantly Improves Blood Sugar Control in People with Type 2 Diabetes Company announces new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome(R) significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs). Landmark Study Shows Diachrome(R) Significantly Improves Blood Sugar Control in People with Type 2 Diabetes Company announces new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome(R) significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs). Research Indicates That Low Glycemic Diet Works Better Than Low-fat Diet For High Insulin Secretors Study published in the Journal of the American Medical Association (JAMA) May 16, 2007 , involving 73 obese adults, aged between 18 to 35 years, at the Children’s Hospital Boston, showed greater weight loss among participants who followed a low glycemic load (GL) diet over a low fat diet. Research Indicates That Low Glycemic Diet Works Better Than Low-fat Diet For High Insulin Secretors Study published in the Journal of the American Medical Association (JAMA) May 16, 2007 , involving 73 obese adults, aged between 18 to 35 years, at the Children’s Hospital Boston, showed greater weight loss among participants who followed a low glycemic load (GL) diet over a low fat diet. Research Indicates That Low Glycemic Diet Works Better Than Low-fat Diet For High Insulin Secretors Study published in the Journal of the American Medical Association (JAMA) May 16, 2007 , involving 73 obese adults, aged between 18 to 35 years, at the Children’s Hospital Boston, showed greater weight loss among participants who followed a low glycemic load (GL) diet over a low fat diet. New Study Links Skeleton with Obesity and Diabetes A study in the journal Cell, “Endocrine Regulation of Energy Metabolism by the Skeleton”, links the vitamin K-dependent protein Osteocalcin to insulin activity and the reduction of obesity and diabetes in mice. New Study Links Skeleton with Obesity and Diabetes A study in the journal Cell, “Endocrine Regulation of Energy Metabolism by the Skeleton”, links the vitamin K-dependent protein Osteocalcin to insulin activity and the reduction of obesity and diabetes in mice. New Study Links Skeleton with Obesity and Diabetes A study in the journal Cell, “Endocrine Regulation of Energy Metabolism by the Skeleton”, links the vitamin K-dependent protein Osteocalcin to insulin activity and the reduction of obesity and diabetes in mice. Scientific Research Indicates That TOYO-FVG(TM) and Astaxanthin Combination Effective for Diabetes Complications According to Toyo Shinyaku Co., Ltd., parent company of Toyo Bio-Pharma(TM), joint research presented as a white paper at the 61st Annual Meeting of the Japanese Society of Nutrition and Food Science indicates that TOYO-FVG and Astaxanthin, used in combination, demonstrated an inhibitory effect on oxidative stress. Scientific Research Indicates That TOYO-FVG(TM) and Astaxanthin Combination Effective for Diabetes Complications According to Toyo Shinyaku Co., Ltd., parent company of Toyo Bio-Pharma(TM), joint research presented as a white paper at the 61st Annual Meeting of the Japanese Society of Nutrition and Food Science indicates that TOYO-FVG and Astaxanthin, used in combination, demonstrated an inhibitory effect on oxidative stress. Scientific Research Indicates That TOYO-FVG(TM) and Astaxanthin Combination Effective for Diabetes Complications According to Toyo Shinyaku Co., Ltd., parent company of Toyo Bio-Pharma(TM), joint research presented as a white paper at the 61st Annual Meeting of the Japanese Society of Nutrition and Food Science indicates that TOYO-FVG and Astaxanthin, used in combination, demonstrated an inhibitory effect on oxidative stress. Beneficial Effects of Salba (A Novel Whole-Grain) Intake on Cardiovascular Risk Factors in Diabetes Researchers from Toronto's St. Michael's Hospital observed that long term supplementation with Salba - a novel whole-grain (Salvia hispanica L.), rich in fiber, alpha-linolenic acid and minerals, "attenuated a major cardiovascular risk factor ... safely beyond conventional therapy, while maintaining good glycemic and lipid control in people with well-controlled type 2 diabetes." Beneficial Effects of Salba (A Novel Whole-Grain) Intake on Cardiovascular Risk Factors in Diabetes Researchers from Toronto's St. Michael's Hospital observed that long term supplementation with Salba - a novel whole-grain (Salvia hispanica L.), rich in fiber, alpha-linolenic acid and minerals, "attenuated a major cardiovascular risk factor ... safely beyond conventional therapy, while maintaining good glycemic and lipid control in people with well-controlled type 2 diabetes." Beneficial Effects of Salba (A Novel Whole-Grain) Intake on Cardiovascular Risk Factors in Diabetes Researchers from Toronto's St. Michael's Hospital observed that long term supplementation with Salba - a novel whole-grain (Salvia hispanica L.), rich in fiber, alpha-linolenic acid and minerals, "attenuated a major cardiovascular risk factor ... safely beyond conventional therapy, while maintaining good glycemic and lipid control in people with well-controlled type 2 diabetes." Study Validates the Benefits of SDG Flax Lignans in Patients With Impaired Glycemic Control The results of randomized, controlled crossover study, published in onlne peer-reviewed journal PLoS (PloS.org) the effects of 360 mg per day SDG flax lignans were investigated in 68 Type 2 diabetic patients. The study utilized Jarrow Formulas Flax Essence(TM) as the source material. Study Validates the Benefits of SDG Flax Lignans in Patients With Impaired Glycemic Control The results of randomized, controlled crossover study, published in onlne peer-reviewed journal PLoS (PloS.org) the effects of 360 mg per day SDG flax lignans were investigated in 68 Type 2 diabetic patients. The study utilized Jarrow Formulas Flax Essence(TM) as the source material. Study Validates the Benefits of SDG Flax Lignans in Patients With Impaired Glycemic Control The results of randomized, controlled crossover study, published in onlne peer-reviewed journal PLoS (PloS.org) the effects of 360 mg per day SDG flax lignans were investigated in 68 Type 2 diabetic patients. The study utilized Jarrow Formulas Flax Essence(TM) as the source material. Study Validates the Benefits of SDG Flax Lignans in Patients With Impaired Glycemic Control The results of randomized, controlled crossover study, published in onlne peer-reviewed journal PLoS (PloS.org) the effects of 360 mg per day SDG flax lignans were investigated in 68 Type 2 diabetic patients. The study utilized Jarrow Formulas Flax Essence(TM) as the source material. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	BATON ROUGE, La., Aug 8, 2006 /PRNewswire via COMTEX/ -- Results from a new study in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.(i) The study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, is published in the August issue of Diabetes Care, an official journal of the American Diabetes Association. The study also found that chromium picolinate significantly reduced the weight gain typically associated with the use of a commonly prescribed antidiabetic medication.(i) These findings are significant as more than two-thirds of people with type 2 diabetes are not at the suggested goal for their blood sugar.(ii) Additionally, more than 80 percent of people with type 2 diabetes are overweight, which can significantly increase their risk of disease-related complications, including cardiovascular disease, which is the leading cause of death amongst patients with diabetes.(iii) "The results further support that chromium may serve as a safe and effective adjunct to medication in helping people with type 2 diabetes improve their blood sugar control. In patients who take a sulfonylurea to control elevated blood sugar, weight gain is common. However, the study findings show that weight gain was less with use of supplemental chromium," said study investigator, William Cefalu, MD, chief of the Center's Division of Nutrition and Chronic Diseases. "Also important is that chromium picolinate helped reduce abdominal fat accumulation, which is associated with a greater risk for other conditions such as abnormal lipids and hypertension." The 40-week randomized, double-blind, placebo-controlled, study was designed to examine the effect of adding daily chromium picolinate supplementation to an antidiabetic medication.(i) Sulfonylurea, a commonly prescribed treatment for type 2 diabetes, was given to 29 subjects for 24 weeks, in conjunction with chromium picolinate or a matching placebo (sugar pill).(i) Blood sugar levels of study participants taking chromium picolinate in combination with the antidiabetic medication dropped significantly compared to the group taking the medication plus placebo (-31.00 +/- 7.37 mg/dL vs. - 11.33 +/- 8.03 mg/dL).(i) In addition, insulin sensitivity, as measured by glucose disposal, for participants taking the medication along with chromium picolinate was increased when compared to those taking the antidiabetic agent and placebo. Study participants taking chromium picolinate also experienced significantly lower abdominal body fat accumulation than the group taking medication and placebo, and experienced less overall weight gain (0.9kg vs. 2.2kg).(i) "It's also important to note that no significant adverse events were reported among the study participants," added Cefalu. The chromium used in this study was provided by Nutrition 21, the makers of Chromax(R) chromium picolinate. The Pennington Biomedical Research Center is a campus of the Louisiana State University System and conducts both clinical and basic research. It is the largest academically based nutrition research center in the world, with the greatest number of obesity researchers on faculty. The Center's nearly 600 employees occupy several buildings on the 234-acre campus. (i) Martin J, Wang Z, Zhang X, Wachtel, D, Volautova J, Matthews D, Cefalu W. Cromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes. Diabetes Care. Volume 29;8: 2006 (ii) American Association of Clinical Endocrinologists. State of Diabetes in America. Available at http://www.aace.com/public/awareness/stateofdiabetes/DiabetesAmericaReport.pdf Last accessed August 1, 2006. (iii) American Diabetes Association. The Link Between Heart Disease and Cardiovascular Disease. Available at http://www.diabetes.org/uedocuments/Factsheetthelink2.pdf Last accessed August 1, 2006.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software